

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.87290012 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 5.87420794 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.49159294 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.10999668 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07395625 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07395625 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.80222040 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.79724554 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66262479 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.35906717 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.30606031 |
| 12 | regulation of B cell differentiation (GO:0045577) | 4.22562181 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.02502040 |
| 14 | neutrophil activation (GO:0042119) | 3.95426805 |
| 15 | detection of other organism (GO:0098543) | 3.90527325 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80301383 |
| 17 | cellular response to zinc ion (GO:0071294) | 3.79344237 |
| 18 | leukocyte aggregation (GO:0070486) | 3.74164099 |
| 19 | detection of bacterium (GO:0016045) | 3.72449285 |
| 20 | hepatocyte apoptotic process (GO:0097284) | 3.72272355 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.67901674 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.64582058 |
| 23 | granulocyte activation (GO:0036230) | 3.62332235 |
| 24 | negative thymic T cell selection (GO:0045060) | 3.53173063 |
| 25 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.50034167 |
| 26 | response to peptidoglycan (GO:0032494) | 3.49485406 |
| 27 | negative T cell selection (GO:0043383) | 3.48144948 |
| 28 | tolerance induction (GO:0002507) | 3.47676631 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 3.47203850 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43301997 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.40368502 |
| 32 | regulation of antigen processing and presentation (GO:0002577) | 3.36788743 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.36419121 |
| 34 | T cell selection (GO:0045058) | 3.32395433 |
| 35 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.32310582 |
| 36 | myeloid dendritic cell activation (GO:0001773) | 3.30244623 |
| 37 | T cell homeostasis (GO:0043029) | 3.30236888 |
| 38 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.29219587 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.28071376 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27308667 |
| 41 | T cell migration (GO:0072678) | 3.26096181 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25569685 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25209418 |
| 44 | negative regulation of B cell proliferation (GO:0030889) | 3.24803397 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.24270737 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23381913 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23066706 |
| 48 | natural killer cell differentiation (GO:0001779) | 3.22491525 |
| 49 | mature B cell differentiation (GO:0002335) | 3.20999165 |
| 50 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.20093980 |
| 51 | lymphocyte homeostasis (GO:0002260) | 3.15041967 |
| 52 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14145897 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14145897 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.13521660 |
| 55 | response to interleukin-15 (GO:0070672) | 3.13344383 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12908053 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.12475455 |
| 58 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.11083016 |
| 59 | response to type I interferon (GO:0034340) | 3.10914453 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.10687613 |
| 61 | germinal center formation (GO:0002467) | 3.09466655 |
| 62 | B cell proliferation (GO:0042100) | 3.09162289 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07963407 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07748428 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.07748428 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 3.07518533 |
| 67 | cellular extravasation (GO:0045123) | 3.06893638 |
| 68 | modulation by symbiont of host immune response (GO:0052553) | 3.06415661 |
| 69 | positive regulation by symbiont of host defense response (GO:0052509) | 3.06415661 |
| 70 | modulation by symbiont of host defense response (GO:0052031) | 3.06415661 |
| 71 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.06415661 |
| 72 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.06415661 |
| 73 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.06415661 |
| 74 | positive T cell selection (GO:0043368) | 3.05750360 |
| 75 | positive regulation of interleukin-2 production (GO:0032743) | 3.05718572 |
| 76 | thymic T cell selection (GO:0045061) | 3.05119684 |
| 77 | cellular response to type I interferon (GO:0071357) | 3.04473679 |
| 78 | type I interferon signaling pathway (GO:0060337) | 3.04473679 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.04121427 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03138162 |
| 81 | regulation of B cell proliferation (GO:0030888) | 2.99509713 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 2.99348447 |
| 83 | respiratory burst (GO:0045730) | 2.97870337 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97786406 |
| 85 | B cell homeostasis (GO:0001782) | 2.97341744 |
| 86 | macrophage activation (GO:0042116) | 2.97116391 |
| 87 | response to host immune response (GO:0052572) | 2.96718107 |
| 88 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96718107 |
| 89 | defense response to protozoan (GO:0042832) | 2.96366471 |
| 90 | positive regulation of interferon-alpha production (GO:0032727) | 2.94394658 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.93254220 |
| 92 | detection of biotic stimulus (GO:0009595) | 2.92432437 |
| 93 | microglial cell activation (GO:0001774) | 2.92085478 |
| 94 | regulation of superoxide anion generation (GO:0032928) | 2.90831057 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89459813 |
| 96 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.88965957 |
| 97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88869939 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.88316730 |
| 99 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86903564 |
| 100 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86574741 |
| 101 | leukocyte homeostasis (GO:0001776) | 2.85203280 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84782395 |
| 103 | response to host (GO:0075136) | 2.84782395 |
| 104 | response to host defenses (GO:0052200) | 2.84782395 |
| 105 | leukocyte cell-cell adhesion (GO:0007159) | 2.84383603 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.83950692 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83180793 |
| 108 | T cell costimulation (GO:0031295) | 2.82986980 |
| 109 | regulation of interferon-alpha production (GO:0032647) | 2.82177485 |
| 110 | serine transport (GO:0032329) | 2.81444539 |
| 111 | mast cell activation (GO:0045576) | 2.81065144 |
| 112 | response to protozoan (GO:0001562) | 2.80062006 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.80000975 |
| 114 | myeloid cell activation involved in immune response (GO:0002275) | 2.79782815 |
| 115 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78550944 |
| 116 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.77325603 |
| 117 | lymphocyte costimulation (GO:0031294) | 2.77063497 |
| 118 | positive regulation of B cell activation (GO:0050871) | 2.76569762 |
| 119 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76564869 |
| 120 | Peyers patch development (GO:0048541) | 2.76564869 |
| 121 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.76372227 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75760801 |
| 123 | regulation of leukocyte degranulation (GO:0043300) | 2.75281945 |
| 124 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73727054 |
| 125 | regulation of mast cell activation (GO:0033003) | 2.73665307 |
| 126 | natural killer cell activation (GO:0030101) | 2.72668969 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.71529771 |
| 128 | regulation of T cell tolerance induction (GO:0002664) | 2.70791260 |
| 129 | V(D)J recombination (GO:0033151) | 2.67972517 |
| 130 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.67721500 |
| 131 | T cell proliferation (GO:0042098) | 2.67664820 |
| 132 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.66280124 |
| 133 | positive regulation of B cell proliferation (GO:0030890) | 2.65678915 |
| 134 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.65307924 |
| 135 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.64747261 |
| 136 | B cell mediated immunity (GO:0019724) | 2.63929676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.89617868 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.52680066 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.07940410 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.40102419 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.19121137 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09075526 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.52971446 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42404944 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.42045975 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.27883484 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.98904304 |
| 12 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.90711157 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89512425 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84649857 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.80923082 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74771330 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74366319 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.67753747 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.66341013 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59378448 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57703162 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.57159412 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54445483 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49644865 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.43530832 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.35090615 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.30948404 |
| 28 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24127628 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22970471 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.21399360 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13821246 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12814865 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03946662 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00177954 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93686026 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87389868 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86984172 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85169616 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82277644 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78570347 |
| 41 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.75050378 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71644626 |
| 43 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.62435724 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.61919592 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54542623 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50771440 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50733925 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47459223 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46394688 |
| 50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46110117 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45338791 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40811361 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.40533460 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40398709 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35964121 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30263981 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29224505 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28385033 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23204640 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22432296 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21929515 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18817078 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15484464 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13814024 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12336795 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12173064 |
| 67 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12038437 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10922656 |
| 69 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10426546 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10091667 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09682576 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08199334 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07697811 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07694359 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03535895 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02981689 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02465713 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01612559 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00752627 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00590039 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00076102 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98889834 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97594958 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96708228 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90352607 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89424822 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89155708 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88554327 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87691847 |
| 90 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86945153 |
| 91 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.86081301 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85956274 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85900443 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85506386 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82875096 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80060444 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78864039 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78591675 |
| 99 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77932944 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76588782 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76173595 |
| 102 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75029470 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74638017 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74354032 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73296176 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73229556 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72277759 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72080757 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.70322739 |
| 110 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.70287054 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.70021682 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.68757886 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68155453 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67829893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40649237 |
| 2 | MP0000685_abnormal_immune_system | 3.96473242 |
| 3 | MP0005387_immune_system_phenotype | 3.64465835 |
| 4 | MP0001790_abnormal_immune_system | 3.64465835 |
| 5 | MP0001800_abnormal_humoral_immune | 3.64257067 |
| 6 | MP0005671_abnormal_response_to | 3.33827416 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.08096270 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.95488730 |
| 9 | MP0003303_peritoneal_inflammation | 2.81636528 |
| 10 | MP0002723_abnormal_immune_serum | 2.78295557 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.71981277 |
| 12 | MP0003436_decreased_susceptibility_to | 2.71899235 |
| 13 | MP0001819_abnormal_immune_cell | 2.69316093 |
| 14 | MP0009785_altered_susceptibility_to | 2.68508429 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.60823546 |
| 16 | MP0002398_abnormal_bone_marrow | 2.54880380 |
| 17 | MP0005025_abnormal_response_to | 2.40674857 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.37908808 |
| 19 | MP0000716_abnormal_immune_system | 2.34164858 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.33590363 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.23285467 |
| 22 | MP0002419_abnormal_innate_immunity | 2.21532373 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.19094076 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.15563242 |
| 25 | MP0002006_tumorigenesis | 2.14150083 |
| 26 | MP0004510_myositis | 2.09895967 |
| 27 | MP0002722_abnormal_immune_system | 2.03740362 |
| 28 | MP0002405_respiratory_system_inflammati | 1.93486772 |
| 29 | MP0002429_abnormal_blood_cell | 1.93258381 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.90631488 |
| 31 | MP0004947_skin_inflammation | 1.83749949 |
| 32 | MP0006082_CNS_inflammation | 1.83712604 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.77843910 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.76170711 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.65578436 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.62129979 |
| 37 | MP0001873_stomach_inflammation | 1.59321839 |
| 38 | MP0006054_spinal_hemorrhage | 1.59298950 |
| 39 | MP0004381_abnormal_hair_follicle | 1.59056245 |
| 40 | MP0002933_joint_inflammation | 1.57194470 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.56716018 |
| 42 | MP0009278_abnormal_bone_marrow | 1.43216769 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.42612332 |
| 44 | MP0005310_abnormal_salivary_gland | 1.42471492 |
| 45 | MP0001853_heart_inflammation | 1.40802467 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.39054271 |
| 47 | MP0003866_abnormal_defecation | 1.35707455 |
| 48 | MP0005451_abnormal_body_composition | 1.29576708 |
| 49 | MP0003724_increased_susceptibility_to | 1.27781701 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.27184514 |
| 51 | MP0003448_altered_tumor_morphology | 1.26847201 |
| 52 | MP0000490_abnormal_crypts_of | 1.20999344 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.20537469 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.20537469 |
| 55 | MP0000858_altered_metastatic_potential | 1.17142652 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.15730047 |
| 57 | MP0004883_abnormal_blood_vessel | 1.11363734 |
| 58 | MP0008260_abnormal_autophagy | 1.10712988 |
| 59 | MP0010307_abnormal_tumor_latency | 1.10237066 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 1.09756131 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.07530063 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.07268174 |
| 63 | MP0008469_abnormal_protein_level | 1.00713426 |
| 64 | MP0000604_amyloidosis | 1.00541096 |
| 65 | MP0010094_abnormal_chromosome_stability | 0.99924092 |
| 66 | MP0005166_decreased_susceptibility_to | 0.98582594 |
| 67 | MP0002009_preneoplasia | 0.98300054 |
| 68 | MP0001851_eye_inflammation | 0.98151793 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.96853184 |
| 70 | MP0003091_abnormal_cell_migration | 0.96008391 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.95597254 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.94271994 |
| 73 | MP0003690_abnormal_glial_cell | 0.94267499 |
| 74 | MP0003075_altered_response_to | 0.93557909 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.93425016 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.91586937 |
| 77 | MP0005164_abnormal_response_to | 0.91000844 |
| 78 | MP0003077_abnormal_cell_cycle | 0.90174251 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.89039565 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.88591770 |
| 81 | MP0009840_abnormal_foam_cell | 0.88125340 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.88095739 |
| 83 | MP0008057_abnormal_DNA_replication | 0.86835647 |
| 84 | MP0003828_pulmonary_edema | 0.84520779 |
| 85 | MP0004130_abnormal_muscle_cell | 0.83249808 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 0.81133442 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.81024282 |
| 88 | MP0000343_altered_response_to | 0.74404899 |
| 89 | MP0005023_abnormal_wound_healing | 0.74119134 |
| 90 | MP0003045_fibrosis | 0.74032771 |
| 91 | MP0000371_diluted_coat_color | 0.70739914 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.69823272 |
| 93 | MP0000249_abnormal_blood_vessel | 0.69635227 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.68567968 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.67565124 |
| 96 | MP0002132_abnormal_respiratory_system | 0.66423888 |
| 97 | MP0001958_emphysema | 0.65939664 |
| 98 | MP0000733_abnormal_muscle_development | 0.65854134 |
| 99 | MP0002254_reproductive_system_inflammat | 0.64579352 |
| 100 | MP0009764_decreased_sensitivity_to | 0.63324077 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.62372159 |
| 102 | MP0008004_abnormal_stomach_pH | 0.61984790 |
| 103 | MP0001663_abnormal_digestive_system | 0.61569517 |
| 104 | MP0003279_aneurysm | 0.61182889 |
| 105 | MP0009115_abnormal_fat_cell | 0.60358045 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.58960864 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.58186355 |
| 108 | MP0004484_altered_response_of | 0.57966625 |
| 109 | MP0009763_increased_sensitivity_to | 0.56759238 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.56037084 |
| 111 | MP0000313_abnormal_cell_death | 0.55148086 |
| 112 | MP0000015_abnormal_ear_pigmentation | 0.54261787 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.53153102 |
| 114 | MP0001915_intracranial_hemorrhage | 0.52887761 |
| 115 | MP0000350_abnormal_cell_proliferation | 0.52614342 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.52479963 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.52287961 |
| 118 | MP0005390_skeleton_phenotype | 0.51852134 |
| 119 | MP0003795_abnormal_bone_structure | 0.50890346 |
| 120 | MP0005621_abnormal_cell_physiology | 0.50717893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.33161714 |
| 2 | Cellulitis (HP:0100658) | 5.40798045 |
| 3 | Recurrent viral infections (HP:0004429) | 4.99207328 |
| 4 | Recurrent bronchitis (HP:0002837) | 4.94746838 |
| 5 | B lymphocytopenia (HP:0010976) | 4.59139506 |
| 6 | Abnormality of B cell number (HP:0010975) | 4.59139506 |
| 7 | Chronic otitis media (HP:0000389) | 4.53245418 |
| 8 | Papilloma (HP:0012740) | 4.52018769 |
| 9 | Verrucae (HP:0200043) | 4.52018769 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.40434615 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.37382849 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.34794475 |
| 13 | Thyroiditis (HP:0100646) | 4.31797482 |
| 14 | Meningitis (HP:0001287) | 4.20613914 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 4.13756380 |
| 16 | Chronic sinusitis (HP:0011109) | 4.01310882 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.92812780 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.90751590 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.83642219 |
| 20 | Colitis (HP:0002583) | 3.80793956 |
| 21 | T lymphocytopenia (HP:0005403) | 3.73494534 |
| 22 | IgM deficiency (HP:0002850) | 3.72178837 |
| 23 | Recurrent sinusitis (HP:0011108) | 3.71952571 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.70970354 |
| 25 | Abnormality of T cell number (HP:0011839) | 3.70749858 |
| 26 | Osteomyelitis (HP:0002754) | 3.63375342 |
| 27 | Lymphopenia (HP:0001888) | 3.48081175 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46967328 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.41347904 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.41347904 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.39476567 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.36641863 |
| 33 | Recurrent pneumonia (HP:0006532) | 3.34772278 |
| 34 | Vasculitis (HP:0002633) | 3.28462365 |
| 35 | Combined immunodeficiency (HP:0005387) | 3.17837836 |
| 36 | Eosinophilia (HP:0001880) | 3.15625091 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.15113218 |
| 38 | Sepsis (HP:0100806) | 3.12626472 |
| 39 | Recurrent skin infections (HP:0001581) | 3.12514258 |
| 40 | Small epiphyses (HP:0010585) | 3.12155135 |
| 41 | Recurrent lower respiratory tract infections (HP:0002783) | 3.09528218 |
| 42 | IgG deficiency (HP:0004315) | 3.06530704 |
| 43 | Abnormality of T cells (HP:0002843) | 3.05733994 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.04438771 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.90721149 |
| 46 | Emphysema (HP:0002097) | 2.90156067 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87306365 |
| 48 | Obstructive lung disease (HP:0006536) | 2.87306365 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79082812 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.76385483 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 2.76063182 |
| 52 | Granulocytopenia (HP:0001913) | 2.73879547 |
| 53 | Bronchitis (HP:0012387) | 2.73625899 |
| 54 | Myositis (HP:0100614) | 2.73356295 |
| 55 | Pustule (HP:0200039) | 2.72357830 |
| 56 | Hemoptysis (HP:0002105) | 2.72239548 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.70846730 |
| 58 | Nasal polyposis (HP:0100582) | 2.69862126 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64817535 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64817535 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64817535 |
| 62 | IgA deficiency (HP:0002720) | 2.63030602 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.56410753 |
| 64 | Leukocytosis (HP:0001974) | 2.54060133 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.50853590 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.49098992 |
| 67 | Lymphoma (HP:0002665) | 2.49025208 |
| 68 | Abnormality of macrophages (HP:0004311) | 2.45940339 |
| 69 | Thrombocytosis (HP:0001894) | 2.45054929 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.41939093 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.40285067 |
| 72 | Restrictive lung disease (HP:0002091) | 2.40142089 |
| 73 | Skin ulcer (HP:0200042) | 2.39302471 |
| 74 | Recurrent otitis media (HP:0000403) | 2.37082562 |
| 75 | Increased IgE level (HP:0003212) | 2.35995510 |
| 76 | Epistaxis (HP:0000421) | 2.33902240 |
| 77 | Vertebral arch anomaly (HP:0008438) | 2.32243999 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29838488 |
| 79 | Hypoplasia of the thymus (HP:0000778) | 2.29523894 |
| 80 | Hematochezia (HP:0002573) | 2.27627481 |
| 81 | Periodontitis (HP:0000704) | 2.26459448 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24249920 |
| 83 | Pulmonary embolism (HP:0002204) | 2.20122777 |
| 84 | Increased cerebral lipofuscin (HP:0011813) | 2.19929559 |
| 85 | Gingival bleeding (HP:0000225) | 2.18555193 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.18048596 |
| 87 | Stomatitis (HP:0010280) | 2.14373915 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.12814418 |
| 89 | Ulnar bowing (HP:0003031) | 2.12430623 |
| 90 | Papilledema (HP:0001085) | 2.11474552 |
| 91 | Mitral stenosis (HP:0001718) | 2.09764533 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.08282109 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.07439123 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.07291320 |
| 95 | Optic neuritis (HP:0100653) | 2.05466259 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 2.05466259 |
| 97 | Encephalitis (HP:0002383) | 2.05429023 |
| 98 | Arterial thrombosis (HP:0004420) | 2.04489502 |
| 99 | Cheilitis (HP:0100825) | 2.04067413 |
| 100 | Skin rash (HP:0000988) | 2.02072077 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.01788307 |
| 102 | Petechiae (HP:0000967) | 2.01582939 |
| 103 | Chronic diarrhea (HP:0002028) | 1.98172474 |
| 104 | Flattened epiphyses (HP:0003071) | 1.96962185 |
| 105 | Slow saccadic eye movements (HP:0000514) | 1.96074949 |
| 106 | Gingivitis (HP:0000230) | 1.95065408 |
| 107 | Leukopenia (HP:0001882) | 1.94991823 |
| 108 | Gangrene (HP:0100758) | 1.94516533 |
| 109 | Orchitis (HP:0100796) | 1.93466040 |
| 110 | Subacute progressive viral hepatitis (HP:0006572) | 1.92823809 |
| 111 | Arthralgia (HP:0002829) | 1.91776999 |
| 112 | Hypoproteinemia (HP:0003075) | 1.91605592 |
| 113 | Spondylolisthesis (HP:0003302) | 1.91433987 |
| 114 | Agnosia (HP:0010524) | 1.91377837 |
| 115 | Glomerulopathy (HP:0100820) | 1.90064609 |
| 116 | Urticaria (HP:0001025) | 1.89264114 |
| 117 | Neutropenia (HP:0001875) | 1.87425563 |
| 118 | Hypergammaglobulinemia (HP:0010702) | 1.85825414 |
| 119 | Viral hepatitis (HP:0006562) | 1.85526962 |
| 120 | Loss of speech (HP:0002371) | 1.84558155 |
| 121 | Abnormality of the intervertebral disk (HP:0005108) | 1.84417199 |
| 122 | Chest pain (HP:0100749) | 1.84130889 |
| 123 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82685075 |
| 124 | Global brain atrophy (HP:0002283) | 1.79988809 |
| 125 | Abnormality of the endocardium (HP:0004306) | 1.78970456 |
| 126 | Fatigue (HP:0012378) | 1.78945378 |
| 127 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.76157755 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.74346149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.61539222 |
| 2 | MAP3K10 | 4.60032899 |
| 3 | PRPF4B | 2.97701676 |
| 4 | STK10 | 2.85597321 |
| 5 | GRK6 | 2.72444607 |
| 6 | BLK | 2.71846448 |
| 7 | MAP3K14 | 2.45332471 |
| 8 | TYK2 | 2.27760053 |
| 9 | SYK | 2.18955829 |
| 10 | BTK | 2.17710156 |
| 11 | JAK3 | 2.14040773 |
| 12 | CSF1R | 1.96064878 |
| 13 | TBK1 | 1.88455213 |
| 14 | MST4 | 1.87676847 |
| 15 | RIPK4 | 1.83780997 |
| 16 | EEF2K | 1.81947047 |
| 17 | LRRK2 | 1.79976069 |
| 18 | KIT | 1.78437407 |
| 19 | ERN1 | 1.77398078 |
| 20 | ZAP70 | 1.77140677 |
| 21 | IKBKE | 1.67127105 |
| 22 | STK4 | 1.66498049 |
| 23 | JAK1 | 1.65432690 |
| 24 | ITK | 1.61107905 |
| 25 | TXK | 1.58069027 |
| 26 | BMPR2 | 1.56414548 |
| 27 | IRAK4 | 1.56002615 |
| 28 | IKBKB | 1.55473572 |
| 29 | MAP3K13 | 1.53858304 |
| 30 | CLK1 | 1.53481285 |
| 31 | CSK | 1.48976228 |
| 32 | MARK3 | 1.47004691 |
| 33 | HCK | 1.46566611 |
| 34 | PIM1 | 1.43563537 |
| 35 | LCK | 1.39228008 |
| 36 | SIK2 | 1.37866385 |
| 37 | LYN | 1.37041276 |
| 38 | TEC | 1.34371898 |
| 39 | PKN2 | 1.29492888 |
| 40 | PIK3CG | 1.26327160 |
| 41 | EPHB1 | 1.25190669 |
| 42 | TAOK3 | 1.19024527 |
| 43 | CDK12 | 1.15795913 |
| 44 | FES | 1.13139896 |
| 45 | NEK9 | 1.11540470 |
| 46 | CDK4 | 1.09845915 |
| 47 | TGFBR2 | 1.09217100 |
| 48 | MAPK12 | 1.08529876 |
| 49 | FGFR3 | 1.07865350 |
| 50 | MAP3K3 | 1.07081114 |
| 51 | SIK3 | 1.01683978 |
| 52 | TRIB3 | 1.01059707 |
| 53 | CDC42BPA | 0.99134312 |
| 54 | NEK2 | 0.98631276 |
| 55 | MAP3K1 | 0.98453895 |
| 56 | MAP2K3 | 0.95751995 |
| 57 | RPS6KA4 | 0.91626789 |
| 58 | RPS6KB2 | 0.89661065 |
| 59 | CAMKK2 | 0.88891653 |
| 60 | TLK1 | 0.88393254 |
| 61 | PRKCQ | 0.86289929 |
| 62 | CDK9 | 0.85779708 |
| 63 | TTN | 0.84774945 |
| 64 | TRPM7 | 0.84754439 |
| 65 | NLK | 0.83455452 |
| 66 | CHUK | 0.83389008 |
| 67 | IRAK1 | 0.80728035 |
| 68 | MAP3K8 | 0.79199415 |
| 69 | FGFR4 | 0.78723440 |
| 70 | PDPK1 | 0.76548426 |
| 71 | KSR2 | 0.75838268 |
| 72 | MATK | 0.75835971 |
| 73 | EIF2AK3 | 0.68616646 |
| 74 | IRAK2 | 0.66057975 |
| 75 | CDK6 | 0.63869710 |
| 76 | MAP3K2 | 0.63529443 |
| 77 | TNK2 | 0.62156057 |
| 78 | TESK2 | 0.62149382 |
| 79 | SMG1 | 0.61977326 |
| 80 | SGK3 | 0.61857687 |
| 81 | YES1 | 0.61563687 |
| 82 | MAP3K7 | 0.59934903 |
| 83 | FLT3 | 0.59289378 |
| 84 | JAK2 | 0.59157458 |
| 85 | DYRK1B | 0.58968159 |
| 86 | GRK7 | 0.58703813 |
| 87 | TAOK1 | 0.57133320 |
| 88 | CAMKK1 | 0.56484079 |
| 89 | HIPK2 | 0.56104358 |
| 90 | SIK1 | 0.54467374 |
| 91 | IRAK3 | 0.53457902 |
| 92 | MELK | 0.52931578 |
| 93 | SGK2 | 0.52899444 |
| 94 | PTK6 | 0.50784912 |
| 95 | ABL1 | 0.50611939 |
| 96 | MAPK4 | 0.49063799 |
| 97 | ICK | 0.48772683 |
| 98 | PRKD2 | 0.48660143 |
| 99 | FGR | 0.48560471 |
| 100 | TAOK2 | 0.47961419 |
| 101 | MAPKAPK2 | 0.47726754 |
| 102 | RPS6KL1 | 0.47288951 |
| 103 | RPS6KC1 | 0.47288951 |
| 104 | RPS6KA5 | 0.46584691 |
| 105 | STK3 | 0.46346910 |
| 106 | PBK | 0.45285870 |
| 107 | PDGFRB | 0.44942095 |
| 108 | MAP3K11 | 0.44897660 |
| 109 | ALK | 0.42701099 |
| 110 | ZAK | 0.42655726 |
| 111 | MAPK11 | 0.41722598 |
| 112 | STK24 | 0.41003858 |
| 113 | FYN | 0.40953217 |
| 114 | WNK1 | 0.40659656 |
| 115 | BRD4 | 0.40573300 |
| 116 | INSR | 0.40271743 |
| 117 | MAP2K2 | 0.40002533 |
| 118 | MOS | 0.39699729 |
| 119 | MAPK7 | 0.37892593 |
| 120 | EGFR | 0.37881359 |
| 121 | PRKCH | 0.37775130 |
| 122 | PKN1 | 0.37378006 |
| 123 | PRKD1 | 0.36418094 |
| 124 | PDK1 | 0.36202761 |
| 125 | MARK2 | 0.35906231 |
| 126 | PRKCD | 0.34529345 |
| 127 | BMX | 0.33043855 |
| 128 | DMPK | 0.32933532 |
| 129 | RPS6KA6 | 0.31006602 |
| 130 | CSNK1D | 0.30475150 |
| 131 | SCYL2 | 0.30026170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.58307869 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.44290387 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65281935 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.61307439 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41259247 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22477315 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.03715161 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01987950 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.95679106 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93333810 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.83386327 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82833301 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.81056364 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72705883 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71429488 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.64956503 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55518911 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.52056660 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51374531 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50746642 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49383217 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49223236 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.47960194 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46835616 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40884868 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.40842632 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39517193 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36497269 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28594213 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.28488711 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28488158 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.26989827 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.26034431 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.22749379 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.22176173 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22053568 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.17762428 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16849556 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15405099 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.15366241 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15251482 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14158240 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12986788 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.12948942 |
| 45 | Mismatch repair_Homo sapiens_hsa03430 | 1.10771508 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09690011 |
| 47 | DNA replication_Homo sapiens_hsa03030 | 1.08220242 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07740930 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.05907282 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05602555 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04560147 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03762973 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03566420 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02379047 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.00206619 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96354540 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95680555 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93304311 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86970642 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.85842253 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83444931 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82454365 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.82230551 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75511183 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74435045 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73356081 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72633120 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68907625 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67874504 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.66075668 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65910940 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62323124 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61137512 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60845326 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60535213 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59817209 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59327667 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59076833 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58861564 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58109983 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56011060 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.55663313 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54281913 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54134784 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53405941 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53136294 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52729315 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.51980296 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.51520914 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.51374994 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51085135 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49914464 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.49905179 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.49428962 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.48359996 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47696436 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47480888 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47412047 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46523910 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45670857 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44121233 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44081617 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43962051 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.43326844 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43159818 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42740726 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41063422 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40984716 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40697252 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.40076698 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.38396345 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.34134679 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.33764094 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.32920661 |
| 115 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31942106 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.31701979 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.30715276 |

